JP2022504181A5 - - Google Patents
Info
- Publication number
- JP2022504181A5 JP2022504181A5 JP2021518472A JP2021518472A JP2022504181A5 JP 2022504181 A5 JP2022504181 A5 JP 2022504181A5 JP 2021518472 A JP2021518472 A JP 2021518472A JP 2021518472 A JP2021518472 A JP 2021518472A JP 2022504181 A5 JP2022504181 A5 JP 2022504181A5
- Authority
- JP
- Japan
- Prior art keywords
- scleroderma
- systemic sclerosis
- compound
- composition
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023055658A JP2023082117A (ja) | 2018-10-03 | 2023-03-30 | 強皮症の治療のための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862740855P | 2018-10-03 | 2018-10-03 | |
| US62/740,855 | 2018-10-03 | ||
| PCT/US2019/054576 WO2020072824A1 (en) | 2018-10-03 | 2019-10-03 | Methods for the treatment of scleroderma |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023055658A Division JP2023082117A (ja) | 2018-10-03 | 2023-03-30 | 強皮症の治療のための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022504181A JP2022504181A (ja) | 2022-01-13 |
| JP2022504181A5 true JP2022504181A5 (enExample) | 2022-09-29 |
| JP7265620B2 JP7265620B2 (ja) | 2023-04-26 |
Family
ID=68290393
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518472A Active JP7265620B2 (ja) | 2018-10-03 | 2019-10-03 | 強皮症の治療のための方法 |
| JP2023055658A Pending JP2023082117A (ja) | 2018-10-03 | 2023-03-30 | 強皮症の治療のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023055658A Pending JP2023082117A (ja) | 2018-10-03 | 2023-03-30 | 強皮症の治療のための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210386706A1 (enExample) |
| EP (1) | EP3860590B1 (enExample) |
| JP (2) | JP7265620B2 (enExample) |
| ES (1) | ES2951870T3 (enExample) |
| WO (1) | WO2020072824A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2786994C (en) | 2010-01-27 | 2018-01-16 | Arena Pharmaceuticals, Inc. | Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
| AU2016205361C1 (en) | 2015-01-06 | 2021-04-08 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
| PL3310760T3 (pl) | 2015-06-22 | 2023-03-06 | Arena Pharmaceuticals, Inc. | Krystaliczna sól L-argininy kwasu (R)-2-(7-(4-cyklopentylo-3-(trifluorometylo)benzyloksy)- 1,2,3,4-tetrahydrocyklo-penta[b]indol-3-ilo)octowego do zastosowania w zaburzeniach związanych z receptorem S1P1 |
| KR20190116416A (ko) | 2017-02-16 | 2019-10-14 | 아레나 파마슈티칼스, 인크. | 원발 담즙성 담관염을 치료하기 위한 화합물 및 방법 |
| JP2020507610A (ja) | 2017-02-16 | 2020-03-12 | アリーナ ファーマシューティカルズ， インコーポレイテッド | 腸管外症状を伴う炎症性腸疾患の治療のための化合物および方法 |
| AU2019280822A1 (en) | 2018-06-06 | 2021-01-07 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1195165A4 (en) | 1999-07-12 | 2005-08-10 | Ono Pharmaceutical Co | FIBROSIS INHIBITORS CONTAINING THE ACTIVE INGREDIENT OF SPHINGOSINE A PHOSPHATE OR ITS RECEPTOR AGONISTS |
| HRP20161133T1 (hr) | 2008-07-23 | 2016-12-02 | Arena Pharmaceuticals, Inc. | DERIVATI SUSPSTITUIRANE 1,2,3,4-TETRAHIDROCIKLOPENTA[b]INDOL-3-IL-OCTENE KISELINE KORISNI U LIJEČENJU AUTOIMUNIH I UPALNIH POREMEĆAJA |
| CA2786994C (en) | 2010-01-27 | 2018-01-16 | Arena Pharmaceuticals, Inc. | Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
| AU2016205361C1 (en) * | 2015-01-06 | 2021-04-08 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
| PL3310760T3 (pl) | 2015-06-22 | 2023-03-06 | Arena Pharmaceuticals, Inc. | Krystaliczna sól L-argininy kwasu (R)-2-(7-(4-cyklopentylo-3-(trifluorometylo)benzyloksy)- 1,2,3,4-tetrahydrocyklo-penta[b]indol-3-ilo)octowego do zastosowania w zaburzeniach związanych z receptorem S1P1 |
| KR20190116416A (ko) * | 2017-02-16 | 2019-10-14 | 아레나 파마슈티칼스, 인크. | 원발 담즙성 담관염을 치료하기 위한 화합물 및 방법 |
| JP2020507610A (ja) * | 2017-02-16 | 2020-03-12 | アリーナ ファーマシューティカルズ， インコーポレイテッド | 腸管外症状を伴う炎症性腸疾患の治療のための化合物および方法 |
| AU2019280822A1 (en) * | 2018-06-06 | 2021-01-07 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
| AU2020206700A1 (en) * | 2019-01-08 | 2021-07-15 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P |
-
2019
- 2019-10-03 WO PCT/US2019/054576 patent/WO2020072824A1/en not_active Ceased
- 2019-10-03 ES ES19790404T patent/ES2951870T3/es active Active
- 2019-10-03 JP JP2021518472A patent/JP7265620B2/ja active Active
- 2019-10-03 EP EP19790404.8A patent/EP3860590B1/en not_active Revoked
- 2019-10-03 US US17/281,748 patent/US20210386706A1/en not_active Abandoned
-
2023
- 2023-03-30 JP JP2023055658A patent/JP2023082117A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3667381B2 (ja) | 解熱鎮痛剤 | |
| JP2023076465A5 (enExample) | ||
| JP5442178B2 (ja) | ロキソプロフェン含有経口用組成物 | |
| JP2015512406A5 (enExample) | ||
| JP2008521784A5 (enExample) | ||
| US20230414519A1 (en) | Rapidly infusing compositions with methotrexate and treatment methods | |
| JP2022516662A5 (enExample) | ||
| JP2022545156A5 (enExample) | ||
| JP2021073257A5 (enExample) | ||
| JP2022511788A5 (enExample) | ||
| JP2013087061A (ja) | 積層錠 | |
| CN111065384A (zh) | 扑热息痛的口腔崩解膜组合物 | |
| JP3122748B2 (ja) | イブプロフェン含有解熱鎮痛剤 | |
| ES2248850T3 (es) | Formulaciones farmaceuticas que contienen sales de potasiom sodio y tris de oxaprozina. | |
| JP2016056195A (ja) | ロキソプロフェン含有経口用組成物５ | |
| JP4614640B2 (ja) | 解熱剤組成物 | |
| JP2023531930A5 (enExample) | ||
| JP2021066751A (ja) | 経口用医薬組成物 | |
| JP6018891B2 (ja) | 解熱鎮痛組成物 | |
| KR20130086771A (ko) | 새로운 조합의 구강내 속붕해 필름형성 조성물 및 ｐｄｅ５ 저해제가 함유된 구강내 속붕해 필름제제 | |
| JP2024511091A5 (enExample) | ||
| JP5742352B2 (ja) | 解熱鎮痛組成物 | |
| JP5303605B2 (ja) | サリチル酸類含有経口組成物 | |
| JP4917255B2 (ja) | サリチル酸類含有経口組成物 | |
| JP2022550458A5 (enExample) |